AdaptHealth (AHCO) vs Pacific Biosciences of California (PACB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pacific Biosciences of California (PACB) has outperformed AdaptHealth (AHCO) over the past year, gaining 52.3% versus a loss of 32.3%. Over five years, AHCO leads with a -76.0% price change compared with -90.6% for PACB. AdaptHealth is the larger company by market cap ($809.1 million vs $714.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AHCO | PACB |
|---|---|---|
| Share price | $6.07 | $2.30 |
| Market cap | $809.13M | $714.91M |
| 1-day change | +3.15% | -15.44% |
| YTD return | -39.11% | +22.99% |
| 1-year return | -32.31% | +52.32% |
| 5-year return | -75.99% | -90.57% |
| EPS (TTM) | $-1.82 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.43 | $3.44 |
| 52-week low | $5.21 | $1.07 |
| Distance from 52-week high | -54.84% | -33.14% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +46.08% | -6.09% |
| Average volume | 2.88M | 10.10M |
| Shares outstanding | 133.41M | 310.83M |
| Employees | 10,900 | 485 |
| Sector | Health Care | Industrials |
| Industry | Medical/Nursing Services | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PACB has outperformed AHCO by 84.6 percentage points over the past year.
- The two companies sit in different sectors: AdaptHealth in Health Care and Pacific Biosciences of California in Industrials.
About AdaptHealth
AHCO stock →AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments.
Health Care · Medical/Nursing Services · 10,900 employees
About Pacific Biosciences of California
PACB stock →Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems.
Industrials · Biotechnology: Laboratory Analytical Instruments · 485 employees
AHCO vs PACB FAQ
Which is bigger, AdaptHealth or Pacific Biosciences of California?
AdaptHealth (AHCO) is larger, with a market capitalization of $809.13M compared with $714.91M for Pacific Biosciences of California (PACB).
Which stock has performed better over the past year, AHCO or PACB?
PACB returned +52.32% over the past 12 months, compared with -32.31% for AHCO (price return, excluding dividends). Past performance does not predict future results.
Are AdaptHealth and Pacific Biosciences of California in the same industry?
No. AdaptHealth is in the Health Care sector, while Pacific Biosciences of California is in Industrials.